Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

Laboratory models show that the beta-blocker, propranolol, can inhibit norepinephrine-induced breast cancer cell migration. We hypothesised that breast cancer patients receiving beta-blockers for hypertension would show reduced metastasis and improved clinical outcome. Three patient subgroups were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Powe, Desmond G., Voss, Melanie J., Zänker, Kurt S., Habashy, Hany O., Green, Andrew R., Ellis, Ian O., Entschladen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248123/
https://www.ncbi.nlm.nih.gov/pubmed/21317458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248123/
https://www.ncbi.nlm.nih.gov/pubmed/21317458

Ejemplares similares